Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/1998
06/10/1998EP0846126A1 Tricyclic antidepressant derivatives and conjugated useful in immunoassays
06/10/1998EP0845998A1 Immunotherapy medicaments containing antibodies which specifically detect the mhcii antigen of a patient to be treated
06/10/1998EP0845995A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection
06/10/1998EP0733106A4 Plant arabinogalactan protein (agp) genes
06/10/1998EP0721346B1 Methods for inducing antigen-specific t cell tolerance
06/10/1998EP0686263A4 Competitive immunoassay utilizing binding protein in a multiclonal antibody format
06/10/1998EP0487627B1 Wound healing preparations containing heparanase
06/10/1998CN1184531A Method for diagnosing a patient for chlamydia
06/10/1998CN1184484A Novel anti-AIDS immunotoxins
06/10/1998CN1038693C Process for fermentative preparation of amino acids
06/09/1998US5763733 Antigen-binding fusion proteins
06/09/1998US5763580 A polypeptide analogs of hgpiib c-terminal fragment, useful for diagnosis of blood clotting and thrombi
06/09/1998US5763578 All-trans retinaldehyde binding protein, and antibodies thereto
06/09/1998US5763574 HIV-specific synthetic antigens and their use
06/09/1998US5763573 GTPase activating protein fragments
06/09/1998US5763572 HTLV-II peptide antigens
06/09/1998US5763570 Glutathione analogs and paralog panels comprising glutathione mimics
06/09/1998US5763441 Administering to the patient suffering from diabetes, glioma, hemangioma, kaposi's sarcoma, ovarian/breast/pancreatic/colon and prostate cancer a benzo(g)quinoxaline compounds
06/09/1998US5763411 Solid support coated with fibrin monomer readily capable of being converted to fibrin polymer sealant or hemostat
06/09/1998US5763410 Kit for preparing a fibrin sealant
06/09/1998US5763274 Antibody 103B2
06/09/1998US5763272 Amino acid sequence of cells for monoclonal antibodies
06/09/1998US5763249 Antibody-mediated reduction of α-ketoamides
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763224 Genetic engineered complementary dna
06/09/1998US5763223 DNA encoding a cytokine that induces apoptosis
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5763219 Cyclin E variants and use thereof
06/09/1998US5763214 Fibroblast growth factor 11
06/09/1998US5763213 Sensory and motor neuron derived factor (SMDF)
06/09/1998US5763211 Polynucleotide which encodes receptor polypeptide
06/09/1998US5763210 Recombinant production of interferon-gamma binding proteins
06/09/1998US5763209 Methods and materials relating to the functional domains of DNA binding proteins
06/09/1998US5763202 Medical diagnosis of prostate cancer; enzyme-linked immunosorbent assay
06/09/1998US5763195 Method and compositions for making ACSF and ACSF antagonists
06/09/1998US5763159 Hepatitis-C virus testing
06/09/1998US5763156 Effective in regulating inflammatory platelet and endothelial sitmulatory and coagulopathic responses by modulating the activity of the c5b-9 complex of the human plasma complement system by adding a fluorescent potentiometric dye
06/09/1998US5762934 Clostridium difficile toxin disease therapy
06/09/1998US5762933 Administering
06/09/1998US5762931 Anti-cancer utility of HCG vaccines
06/09/1998US5762930 Bispecific reagents for redirected targeting of human lipoproteins
06/09/1998US5762927 Exposing primate to immunotoxin, administering lymph node lymphocytes, transplanting organ
06/09/1998US5762921 Composition and methods for the treatment of tumors
06/09/1998US5762906 Further improvements relating to radiolabelling of proteins
06/09/1998US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus
06/09/1998US5762805 Transferring matter to or from blood, semipermeable membranes, filters and controlling flow
06/04/1998WO1998023963A1 Methods and reagents for determining protein s
06/04/1998WO1998023775A2 Dna for evaluating the progression potential of cervical lesions
06/04/1998WO1998023761A1 HUMANIZED ANTI-CD11a ANTIBODIES
06/04/1998WO1998023760A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/04/1998WO1998023759A2 Identification of inhibitors that prevent access of telomerase to chromosomal terminus
06/04/1998WO1998023755A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/04/1998WO1998023752A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
06/04/1998WO1998023750A2 Mammalian chemokines
06/04/1998WO1998023749A1 Fibroblast growth factor-13
06/04/1998WO1998023746A1 Antibody mutants
06/04/1998WO1998023745A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998WO1998023743A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses
06/04/1998WO1998023737A1 Production of in vivo labeled single chain synthetic antibody fragments
06/04/1998WO1998023646A2 Binding agents specific for iga receptor
06/04/1998WO1998023645A1 Affinity purification of polypeptide on protein a matrix
06/04/1998WO1998023641A1 Dna encoding lepidopteran-active delta-endotoxins and its use
06/04/1998WO1998023631A1 Novel bacterial polypeptides and polynucleotides
06/04/1998WO1998023289A1 MODULATION OF IgG BINDING TO FcRn
06/04/1998WO1998023287A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
06/04/1998WO1998023286A2 Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy
06/04/1998WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
06/04/1998WO1998000171A3 Conjugates of thrombin inhibitors and endogenes carriers
06/04/1998CA2274313A1 Mammalian chemokines
06/04/1998CA2274143A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998CA2272989A1 Identification of inhibitors that prevent access of telomerase to chromosomal terminus
06/04/1998CA2272847A1 Dna encoding lepidopteran-active delta-endotoxins and its use
06/04/1998CA2272632A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
06/04/1998CA2272239A1 Fibroblast growth factor-13
06/04/1998CA2270283A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998CA2243944A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/03/1998EP0845540A1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same
06/03/1998EP0845535A2 Leader peptidase (lep) from Streptococcus
06/03/1998EP0845529A2 Human G-protein coupled receptor protein cloned form fetal brain CDNA library
06/03/1998EP0845037A1 Globulin protein 11s, usable as a seed impregnation marker during germination.
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0845035A2 Urocortin peptides
06/03/1998EP0845007A2 Pharmaceutical composition containing inhibitors of interferon-gamma
06/03/1998EP0845006A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
06/03/1998EP0845005A1 Traf inhibitors
06/03/1998EP0845004A1 Epitope tagging system
06/03/1998EP0844885A2 Chemical compounds
06/03/1998EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS
06/03/1998EP0833834A4 Dna sequence and encoded mammary-specific breast cancer protein
06/03/1998CN1183811A Method for isolation and purification of lipid cell-wall components
06/03/1998CN1183806A Polynucleotide immunogenic agents
06/03/1998CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies
06/03/1998CN1183802A Method for producing immunoglobulins contg. protection proteins in plants and their use
06/02/1998US5760186 Inflammatory cytokine, diagnosis and therapy
06/02/1998US5760185 Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody
06/02/1998US5760181 Endotoxins
06/02/1998US5760180 Kits and dna(cdna) codes and cloning expression vectors
06/02/1998US5760178 Antitumor
06/02/1998US5760166 Having available anhydride functional groups capable of immobilizing biological molecules and hydrolyzed anhydride functional groups